Further, the behavioral and molecular signs of fibromyalgia were also depleted by Trpv1 gene deletion and the injection of a CB1 agonist, while the injection of a CB1 antagonist blocked the therapeutic effects of EA. The gene discussed is TRPV1; the disease is fibromyalgia.